Mona Synnøve Nilsen

PhD Candidate

Obesity. Type 2 diabetes. Adipose tissue. Metabolism.

Involved in teaching of bachelor students in human nutrition

Co-supervising master students

Academic article

Show author(s) 2021. Role of the Neutral Amino Acid Transporter Slc7a10 in Adipocyte Lipid Storage, Obesity and Insulin Resistance. Diabetes.
Show author(s) 2021. Role of the Neutral Amino Acid Transporter Slc7a10 in Adipocyte Lipid Storage, Obesity and Insulin Resistance. Diabetes.
Show author(s) 2021. Plasma 3-hydroxyisobutyrate (3-HIB) and methylmalonic acid (MMA) are markers of hepatic mitochondrial fatty acid oxidation in male Wistar rats. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids.

Show author(s) 2020. 3-hydroxyisobutyrate, a strong marker of insulin resistance in type 2 diabetes and obesity that modulates white and brown adipocyte metabolism. Diabetes. 1903-1916.

Academic lecture

Show author(s) 2020. Low 3-hydroxyisobutyrate (3-HIB) and high methylmalonic acid (MMA) levels in plasma reflect increased hepatic fatty acid oxidation.

Show author(s) 2019. Circulating 3-hydroxyisobutyrate (3-HIB) as a clinical marker of prediabetes and T2D in patients with obesity.
Show author(s) 2019. A novel amino acid transporter modulating insulin resistance via adipocytes .

Poster

Show author(s) 2019. Inhibition of serine transporter SLC7A10 promotes lipid accumulation through altered BCAA catabolism in adipocytes.
Show author(s) 2019. Adipocyte amino acid metabolism in obesity-related metabolic diseases .

Board member in Research School in Clinical Medicine

PhD project: "Branched-chain amino acid metabolism in obesity and insulin resistance"